Should I Buy EXOZ? EXOZ 2026 Analysis

Should You Buy eXoZymes Inc (EXOZ) Today? Analysis, Price Targets, and 2026 Outlook.

Conclusion

Hold

Latest Price

10.190

1 Day change

-1.74%

52 Week Range

23.990

Analysis Updated At

2026/01/29

eXoZymes Inc (EXOZ) is not a strong buy at the moment for a beginner investor with a long-term strategy. The stock lacks positive momentum, has no significant trading signals, and its financials show no revenue growth with negative net income. While there are no major negative catalysts, there are also no strong positive drivers to justify an immediate investment.

Technical Analysis

The MACD is slightly positive at 0.12 but contracting, suggesting weakening momentum. RSI at 32.183 is neutral, indicating no oversold or overbought conditions. Moving averages are converging, showing no clear trend. The stock is trading near its S1 support level of 10.22, with resistance at 11.424, suggesting limited upside potential in the short term.

Options Data

Positive Catalysts

NULL identified. No recent news or significant insider or hedge fund activity. MACD is slightly positive, but the signal is weak.

Neutral/Negative Catalysts

The stock has declined 1.74% in the last session and is trading near its support level. Financials show no revenue growth, negative net income, and negative EPS. No recent news or catalysts to drive the stock upward.

Financial Performance

In Q3 2025, the company reported no revenue growth (0% YoY), a net income of -$2,286,991 (up 38.07% YoY), and an EPS of -0.27 (up 35% YoY). Gross margin remains at 0%. While losses have narrowed, the company is still not profitable.

Growth

Profitability

Efficiency

Analyst Ratings and Price Target Trends

No analyst rating or price target changes available.

Analyst Rating

Wall Street analysts forecast EXOZ stock price to rise over the next 12 months. According to Wall Street analysts, the average 1-year price target for EXOZ is 0 USD with a low forecast of 0 USD and a high forecast of 0 USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.

Buy

Hold

Sell

Current: 10.370

Low

Averages

High